| 000 | 01311 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515182959.0 | ||
| 264 | 0 | _c20091001 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1790-5427 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAleksić, Aleksandar | |
| 245 | 0 | 0 |
_aTSH receptor antibodies for confirming the diagnosis and prediction of remission duration, in newly diagnosed Graves' disease patients. _h[electronic resource] |
| 260 |
_bHellenic journal of nuclear medicine _c |
||
| 300 |
_a146-50 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraves Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoglobulins, Thyroid-Stimulating |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aTechnetium |
| 650 | 0 | 4 |
_aThyrotropin _xtherapeutic use |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aAleksić, Zeljka | |
| 700 | 1 | _aStojanović, Miodrag | |
| 773 | 0 |
_tHellenic journal of nuclear medicine _gvol. 12 _gno. 2 _gp. 146-50 |
|
| 999 |
_c19081660 _d19081660 |
||